In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma
β Scribed by M. Nestor; M. Persson; G. A. M. S. Dongen; H. J. Jensen; H. Lundqvist; M. Anniko; V. Tolmachev
- Book ID
- 105962594
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 181 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. The effectiveness of chemotherapeutic agents is proportional to the dose of the agents at their targets; however, the dose is limited by systemic toxicity. Attempts have been made to improve therapeutic effectiveness by increasing maximum tolerated dose (MTD) of chemothe
Nude mice carrying human squamous-cell carcinoma xenografts were given i.v. injections of radiolabelled monoclonal antibodies (Mas). MAb E 48, which reacts with squamouscell carcinomas, was labelled with i3'l, while a second control MAb of similar immunoglobulin subclass was labelled with lZ5l. Both